Blue Cross Laboratories
Blue Cross Laboratories, headquartered in Indiana, is a prominent player in the pharmaceutical and biotechnology industry. Founded in [year not specified], the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including generic medications and specialty drugs. With a strong operational presence across the United States, Blue Cross Laboratories is recognised for its commitment to innovation and quality assurance. The company’s core offerings are distinguished by their rigorous testing protocols and adherence to regulatory standards, ensuring safety and efficacy. Notable achievements include [key milestones not specified], which have solidified its market position as a trusted provider in the healthcare sector. Blue Cross Laboratories continues to focus on advancing healthcare solutions, making significant contributions to patient care and treatment options.
DitchCarbon Score
How does Blue Cross Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Blue Cross Laboratories's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Blue Cross Laboratories's reported carbon emissions
In 2021, Blue Cross Laboratories reported total carbon emissions of approximately 1,181,000 kg CO2e in Great Britain, comprising 319,000 kg CO2e from Scope 1 (stationary combustion) and 449,000 kg CO2e from Scope 2 (purchased electricity). This marked a reduction from 2020, where total emissions were about 1,325,000 kg CO2e, indicating a commitment to lowering their carbon footprint. Despite these reductions, there are currently no specific reduction targets or climate pledges disclosed by Blue Cross Laboratories. The absence of formal commitments suggests a need for further initiatives to enhance their sustainability efforts. The company operates within an industry increasingly focused on climate action, highlighting the importance of establishing measurable goals to align with global climate standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Blue Cross Laboratories is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
